Fig. 7From: Gene expression profiles separate endometriosis lesion subtypes and indicate a sensitivity of endometrioma to estrogen suppressive treatments through elevated ESR2 expressionGene expression of receptors targeted by hormonal treatments in different lesion subtypes. The level of expression was determined for hormone receptors that can be targeted by hormones used for endometriosis treatment. We identified a significantly increased expression of a ESR2 in OMA compared to all other lesions and significantly decreased expression of b ESR1 and d PGR was observed. No significant differences were observed for c AR, e PGRMC1, f PGRMC2, g GnRH1, h GnRH2 and i MCRBack to article page